Buscar
Eikon Therapeutics Ord Shs
EIKNAñadir a la lista de seguimiento
12.540USD
+0.290+2.37%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
663.20MCap. mercado
PérdidaP/E TTM
Más Datos de Eikon Therapeutics Ord Shs Compañía
Información de Eikon Therapeutics Ord Shs
Símbolo de cotizaciónEIKN
Nombre de la empresaEikon Therapeutics Inc
Fecha de salida a bolsaFeb 05, 2026
Director ejecutivoPerlmutter (Roger M)
Número de empleados384
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 05
Dirección230 Harriet Tubman Way
CiudadMILLBRAE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94030
Teléfono13026587581
Sitio Webhttps://eikontx.com/
Símbolo de cotizaciónEIKN
Fecha de salida a bolsaFeb 05, 2026
Director ejecutivoPerlmutter (Roger M)
Ejecutivos de Eikon Therapeutics Ord Shs
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Eikon Therapeutics Ord Shs?
Los cinco principales accionistas de Eikon Therapeutics Ord Shs son: Dr. Roger M. Perlmutter, M.D., Ph.D.